Precision BioSciences Inc (DTIL) — Capital Reinvestment Ratio

Latest as of September 2022: 0.04x

Precision BioSciences Inc (DTIL) has a Capital Reinvestment Ratio of 0.04x as of September 2022, meaning it reinvests 0% of its operating cash flow ($29.19 Million) in capital expenditures ($1.09 Million). See Precision BioSciences Inc net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.04x

Capex / Operating Cash Flow

Operating Cash Flow

$29.19 Million

USD

Capital Expenditures

$1.09 Million

USD

Data as of

Sep 2022

Most recent filing

Precision BioSciences Inc Capital Reinvestment Ratio (2016–2016)

This chart tracks Precision BioSciences Inc's Capital Reinvestment Ratio across 1 annual periods. Check DTIL cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Precision BioSciences Inc (2016–2016)

Year-by-year Capital Reinvestment Ratio for Precision BioSciences Inc from 2016 to 2016. For live market cap and broader valuation context, see Precision BioSciences Inc (DTIL) total market value.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change
2016	0.02x	$92.27 Million	$2.08 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow